J., Lee I
While weight reduction is a beneficial effect in type 2 diabetes management, it's important to note that Mounjaro is specifically licensed for diabetes treatment in the UK, not as a weight management medication
New England Journal Of Medicine *In a 68-week placebo-controlled study of 1,961 obese and overweight non-diabetic adults with weight-related conditions, those on semaglutide lost on average 14.9% of their weight as opposed to 2% of the placebo group
Tirzepatide, a dual GLP-1 and GIP receptor agonist, slows stomach emptying and affects how your body processes glucoseboth factors that interact with alcohol in ways that can amplify side effects
[2] Disruption at any stage of this tightly regulated system, whether through impaired insulin secretion, reduced tissue responsiveness, excessive glucose production by the liver, or hormonal imbalance, can result in sustained hyperglycemia